Elevated plasma SAA3 levels promotes plaque formation, as demonstrated in susceptible mouse models [70–72], linking particle and fiber-induced pulmonary acute phase response to atherosclerosis and thereby cardiovascular disease. Here, SAA3P is linked to cardiovascular disorder.